AstraZeneca Korea CEO Kim Sang-pyo wins presidential citation on the 33rd Drug Day
AstraZeneca Korea CEO Kim Sang-pyo wins presidential citation on the 33rd Drug Day
  • Lee Kap-soo
  • 승인 2019.11.20 12:51
  • 댓글 0
이 기사를 공유합니다

Kim Sang-pyo, CEO of AstraZeneca Korea, won the presidential citation at the ceremony for the "33rd Drug Day" at the Westin Chosun Hotel in central Seoul on Nov. 18. (Courtesy of AstraZeneca Korea)

Kim Sang-pyo, CEO of AstraZeneca Korea, won the presidential citation at the ceremony for the "33rd Drug Day" at the Westin Chosun Hotel in central Seoul on Nov. 18.

Kim was credited with promoting multi-faceted external cooperation to innovate the local bio health industry and help local companies advance into the global market, and thus contributing to the development of the local pharmaceutical industry.

He was mainly responsible for communication with AstraZeneca's headquarters and other related ministries in Korea, leading to the headquarters' decision to invest in the local bio health industry for five years starting next year.

In addition, Kim signed a letter of intent (LOI) with the Korea Trade-Investment Promotion Agency (KOTRA) and the Korea Bio Association in June and proposed a win-win model and measures to globalize the development of the Korean pharmaceutical industry, including clinical research and open innovation cooperation for the development of new drugs.

As part of its action plan, President Kim consistently said, "We have continued cooperative activities for the development of the Korean bio health industry by holding a meeting to pass on know-how to advance into China and seeking opportunities for business cooperation with local companies in China, while holding symposiums on the development of new drugs using artificial intelligence with the British Embassy."

"We are honored that AstraZeneca is a global company that has been recognized as a partner to contribute to domestic industry development and society," said CEO Kim, adding, "AstraZeneca will continue to work to promote growth of the domestic bio health industry and produce meaningful results in order to provide better treatment for patients in the future."


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • URL: www.koreaittimes.com / m.koreaittimes.com. Editorial Div. 02-578-0434 / 010-2442-9446. Email: info@koreaittimes.com.
  • Publisher: Monica Younsoo Chung. CEO: Lee Kap-soo. Editor: Jung Yeon-jin. Juvenile Protection Manager: Yeon Choul-woong.
  • IT Times Canada: Willow St. Vancouver BC, Canada / 070-7008-0005.
  • Copyright(C) Korea IT Times, Allrights reserved.
ND소프트